CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 1,183,198 Value ($000) $4,969 Avg Close — Range —
Q4 2022
Shares 1,200,073 Value ($000) $7,212 Avg Close — Range —
Q3 2022
Shares 1,535,544 Value ($000) $9 Avg Close — Range —
Q2 2022
Shares 647,596 Value ($000) $4 Avg Close — Range —
Q1 2022
Shares 349,175 Value ($000) $1,631 Avg Close — Range —
Q4 2021
Shares 61,047 Value ($000) $152 Avg Close — Range —
Q2 2021
Shares 41,558 Value ($000) $104 Avg Close — Range —
Q4 2020
Shares 57,586 Value ($000) $185 Avg Close — Range —
Q4 2019
Shares 13,131 Value ($000) $21 Avg Close — Range —
Q2 2019
Shares 379,279 Value ($000) $326 Avg Close — Range —
Q4 2018
Shares 11,272 Value ($000) $8 Avg Close — Range —
Q3 2018
Shares 16,208 Value ($000) $35 Avg Close — Range —
Q2 2018
Shares 82,738 Value ($000) $412 Avg Close — Range —
Q1 2018
Shares 422,954 Value ($000) $1,650 Avg Close — Range —
Q2 2017
Shares 23,412 Value ($000) $77 Avg Close — Range —
Q1 2017
Shares 51,355 Value ($000) $216 Avg Close — Range —